AstraZeneca mini oral: Transforming GDMT: The iHALO approach to heart failure excellence
| Friday, August 15, 2025 |
| 10:15 AM - 10:45 AM |
| Theatrette 7 |
Details
The iHALO project was led by Professor Aaron Sverdlov and this session will provide insights into initiatives aimed at improving guideline directed medical therapy (GDMT) for in-patients and outpatients diagnosed with heart failure.
This initiative was led by the Hunter New England Local Health District and supported by AstraZeneca.
This initiative was led by the Hunter New England Local Health District and supported by AstraZeneca.
Speaker
Dr Gary Gan
Consultant Cardiologist
Western Sydney Local Health District
Transforming GDMT: The iHALO approach to heart failure excellence
10:15 AM - 10:45 AMBiography
Clinical Lead of the Heart Failure Services at Westmead Hospital and Blacktown Hospital
Clinical Lead for Cardiac Imaging at Ryde Hospital
Co-chair for the Emerging Leaders Heart Failure committee
Senior Conjoint Lecturer University of Western Sydney
Clinical Lead for Cardiac Imaging at Ryde Hospital
Co-chair for the Emerging Leaders Heart Failure committee
Senior Conjoint Lecturer University of Western Sydney
Prof Aaron Sverdlov
Cardiologist
John Hunter Hospital
Transforming GDMT: The iHALO approach to heart failure excellence
10:15 AM - 10:45 AMBiography
Heart Foundation Future Leader Fellow
Professor in Cardiology & Director of Heart Failure | University of Newcastle
Clinical Lead - Heart Failure & Cardio-Oncology
Co-Director | Newcastle Centre of Excellence in Cardio-Oncology
Clinical Academic – Cardiologist | John Hunter Hospital
Professor in Cardiology & Director of Heart Failure | University of Newcastle
Clinical Lead - Heart Failure & Cardio-Oncology
Co-Director | Newcastle Centre of Excellence in Cardio-Oncology
Clinical Academic – Cardiologist | John Hunter Hospital
